h.almeida
TL2 Member · Augsburg, DE
UK-based. Mostly the access and pricing categories.
Joined 18 October 2024 · last posted 2d · groups: regional-uk
92 posts, newest first. Showing up to 150.
-
Sleep quality changes during weight loss Replied, post #30 · Wellbeing › Sleep · 26 Jul 2026 · 0 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #96 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 2 likes Post #93 describes the usual case. This is about the unusual one. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #83 · Access › Insurance & coverage · 19 Jul 2026 · 21 likes Where I part company with post #81, and it is a narrow parting. I would put moderate confidence on the mainstream reading of Prior authorisation and no more. That is…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 19 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
What a certificate commits its issuer to Replied, post #41 · Analytics › COA interpretation · 16 Jul 2026 · 16 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #48 · Practice › Interactions · 15 Jul 2026 · 0 likes The most useful reply I ever got about Antibiotics was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #9 · Compounds › Repair & healing peptides · 1 Jul 2026 · 29 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. Marking that as an…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #66 · Compounds › Oral incretins · 29 Jun 2026 · 3 likes Fair, and the limits you put on it are the part I will remember.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #44 · Sourcing › Independent verification · 26 Jun 2026 · 7 likes Answering the question post #40 raises rather than the one it answers. Interpreting a result: I have looked for the primary source twice and failed twice. Either it…
-
Conditions that change the calculus rather than forbidding it Replied, post #24 · Safety › Contraindications · 22 Jun 2026 · 3 likes This follows post #21 rather than contradicting it. Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest…
-
Private prescribing in the UK: what is actually involved Replied, post #37 · Regional › UK & Ireland · 13 Jun 2026 · 11 likes Answering the question post #33 raises rather than the one it answers. Waiting times are the most variable and least generalisable thing reported here, and they are…
-
Racemisation and why it is invisible to a mass measurement Replied, post #34 · Analytics › Impurities & related substances · 10 Jun 2026 · 1 like Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #45 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 17 likes Adding what did not work for me on peak-to-trough ratio, since the failures never get written up and they are half the useful information.
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #36 · Clinical › Special populations · 2 Jun 2026 · 0 likes Post #35 is the version of this I will quote in future. One addition. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #28 · Analytics › Home & field testing · 23 May 2026 · 1 like A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
-
The best-written scientific paper you have read Replied, post #48 · Lounge › Off topic · 16 May 2026 · 26 likes Best-written scientific paper: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I…
-
Bioimpedance and hydration: why the number moves Replied, post #44 · Outcomes › Body composition · 13 May 2026 · 14 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Private prescribing in the UK: what is actually involved Replied, post #8 · Regional › UK & Ireland · 3 May 2026 · 5 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Reading a home test result without over-claiming Replied, post #17 · Analytics › Home & field testing · 19 Apr 2026 · 0 likes Picking up post #15: that is the part I would want checked first. A control sample of known material run alongside is what turns a home test from an impression into a…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #46 · Practice › Interactions · 16 Apr 2026 · 17 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
-
Sample handling between despatch and injection Replied, post #30 · Analytics › Method validation · 10 Apr 2026 · 7 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #4 · Devices › Syringes & needles · 1 Apr 2026 · 6 likes 0.3 ml versus 0.5 ml would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Preservatives: function, testing, and limits — one year on Replied, post #5 · Pharmacology › Formulation chemistry · 18 Mar 2026 · 5 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. The version of Preservatives that circulates here is a…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #10 · Analytics › Mass spectrometry · 18 Mar 2026 · 0 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #15 · Evidence › Trials · 28 Feb 2026 · 0 likes Small correction to my own earlier position on Composite endpoints. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #12 · Analytics › HPLC & UHPLC · 25 Feb 2026 · 25 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Measurement error in a self-reported exposure Replied, post #61 · Evidence › Study critique · 25 Feb 2026 · 1 like Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
-
Temperature indicator cards: worth asking for? Replied, post #3 · Sourcing › Logistics · 23 Feb 2026 · 21 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #119 · Practice › Dosing & titration · 21 Feb 2026 · 15 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
-
Journal club: LEADER as the historical anchor Replied, post #37 · Evidence › Journal club · 20 Feb 2026 · 24 likes Fair, and the limits you put on it are the part I will remember.
-
Managing an unplanned gap in supply Replied, post #34 · Access › Shortages · 17 Feb 2026 · 7 likes On post #32 — agreed on the reasoning, with one qualification. Where a manufacturer publishes a supply statement, that document is more reliable than any aggregation of…
-
A single out-of-range value on an otherwise normal panel Replied, post #12 · Clinical › Bloodwork · 8 Feb 2026 · 21 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial. Scoping that to…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #61 · Regional › UK & Ireland · 12 Jan 2026 · 9 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #9 · Practice › Storage & stability · 31 Dec 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Someone should write this up properly,…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #3 · Sourcing › Vendor reports · 22 Dec 2025 · 20 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. If that is already documented…
-
Tracking a preprint to publication: a worked example Replied, post #145 · Evidence › Preprints · 14 Dec 2025 · 6 likes Noted, and I have changed what I was going to do on the strength of it.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #17 · Practice › Side effects · 18 Nov 2025 · 29 likes Posting my Dizziness on standing numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #47 · Compounds › Tirzepatide · 12 Nov 2025 · 8 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Managing an unplanned gap in supply — what changed since Replied, post #111 · Access › Shortages · 9 Nov 2025 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
-
Reading SURMOUNT-1 without the press release Replied, post #59 · Compounds › Tirzepatide · 8 Nov 2025 · 1 like A request rather than an answer: could whoever has the primary source for reading SURMOUNT-1 without the press post it? I have seen the claim three times this month and…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #14 · Practice › Storage & stability · 22 Oct 2025 · 0 likes Worth separating two things that post #11 runs together. The arithmetic on Storing lyophilised material long term is the easy part and it is where the errors are, which…
-
Reading an interaction checker output critically Replied, post #15 · Practice › Interactions · 3 Oct 2025 · 7 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
-
Payment method and the leverage it gives you, ranked Replied, post #4 · Sourcing › Payments · 12 Sep 2025 · 15 likes The site does not carry prices, payment details or transaction routes, and questions asking for them will be answered with that rather than with a link. I would treat…
-
High-resolution MS on aggregates and what it can see Replied, post #63 · Analytics › Mass spectrometry · 8 Sep 2025 · 0 likes Post #61 answers the question as asked. The question underneath it is different. What I want from this high-resolution thread is the list of things that would need to…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #34 · Evidence › Journal club · 4 Sep 2025 · 0 likes Narrowing post #31, because the general version has more than one answer. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
A comparison of home results against a laboratory result on the same vial Replied, post #31 · Analytics › Home & field testing · 31 Aug 2025 · 24 likes I had written a reply contradicting post #27 and deleted it. Here is what survived. Why third-party testing is stronger: a home test run by the person who made the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #2 · Research Methods › N-of-1 designs · 25 Aug 2025 · 4 likes An n of one tells you about one person, which is the person you are most interested in. That is the whole value and it is not nothing. I would put the burden of proof…
-
Specification in the result column: why that is a meaningful error Replied, post #35 · Analytics › COA interpretation · 24 Aug 2025 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #57 · Compounds › Retatrutide · 21 Aug 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #34 · Analytics › COA interpretation · 17 Aug 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
System suitability injections: if they failed, the run did not happen Replied, post #23 · Analytics › HPLC & UHPLC · 16 Aug 2025 · 3 likes Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre 250 millimetre column and a sub-2 micrometre 100 millimetre column…
-
When to stop reading forums, including this one Replied, post #15 · Wellbeing › Mental health · 15 Aug 2025 · 1 like Confirming post #14 from a second method, which matters more than confirming it from a second person. Support and community: some people process weight change through…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #20 · Evidence › Journal club · 15 Aug 2025 · 6 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
A ten-fold dose error caught before injection — one year on Replied, post #125 · Devices › Syringes & needles · 4 Aug 2025 · 4 likes Everything in post #121 holds. The case it does not cover is the one I have. Reading units correctly: look at the marking from the side, not from above or below. The…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #12 · Practice › Reconstitution · 22 Jul 2025 · 14 likes Narrowing post #9, because the general version has more than one answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #82 · Wellbeing › Mental health · 3 Jul 2025 · 3 likes Everything in post #79 holds. The case it does not cover is the one I have. The failure mode on history of disordered eating is boring rather than dramatic. It is…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #129 · Clinical › Comorbidities · 29 Jun 2025 · 27 likes Renal function affects clearance for some compounds in this class and not others. The published data is compound-specific and is worth checking rather than…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #145 · Practice › Reconstitution · 25 Jun 2025 · 24 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Substitution between formats during a shortage Replied, post #11 · Access › Shortages · 18 Jun 2025 · 9 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #135 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 0 likes Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the two are not additive in a simple way when the drugs are combined. The…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #11 · Sourcing › Vendor reports · 11 Jun 2025 · 8 likes Noted, and I have changed what I was going to do on the strength of it.
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #13 · Sourcing › Payments · 6 Jun 2025 · 7 likes Recording the time from payment to dispatch is worth doing, because it is the part of the process most within the supplier's control.
-
Coming back to: When "no data" is the complete and final answer Replied, post #3 · Compounds › Other compounds · 31 May 2025 · 26 likes Everything in the opening post holds. The case it does not cover is the one I have. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Follow-up: What other technical communities get right that we do not Replied, post #101 · Lounge › Off topic · 18 May 2025 · 6 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. Same conclusion as the reply above,…
-
What a 2 ppm match establishes, and what it does not Replied, post #18 · Analytics › Mass spectrometry · 15 May 2025 · 0 likes Calibration state at the time of the run determines whether the ppm figure means anything. A report that states when the instrument was last calibrated is unusual and…
-
Reading order for a first week here, and what to skip until later Replied, post #114 · Start Here › Welcome · 3 May 2025 · 0 likes Reading order would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #38 · Practice › Reconstitution · 16 Apr 2025 · 1 like Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
-
Regression to the mean in progress reports Started this topic · Research Methods › Statistics · 10 Apr 2025 · 58 likes On the subject in the title: Regression to the mean in progress reports Working notes rather than a conclusion. Something about regression does not reconcile and I…
-
Transit times by route, from a logged dataset — the long version Replied, post #76 · Sourcing › Logistics · 30 Mar 2025 · 23 likes Two people in this thread mean different things by Transit times and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #20 · Sourcing › Vendor reports · 24 Mar 2025 · 2 likes Reports naming a supplier need the evidence attached, which is a guideline rather than a formality. It is what makes the record usable and it is what keeps it fair.
-
Criticising the method without criticising the authors Replied, post #49 · Evidence › Study critique · 22 Mar 2025 · 31 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Reading a chromatogram someone posted without axes Replied, post #13 · Analytics › HPLC & UHPLC · 21 Mar 2025 · 3 likes Post #12 is right about the mechanism and I think understates the practical bit. What I would want before treating reading a chromatogram as settled: the method, the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #79 · Evidence › Journal club · 17 Mar 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #61 · Wellbeing › Mental health · 13 Mar 2025 · 18 likes Tracking mood alongside dose and weeks, on a simple scale, produces a record that is far more useful than a recollection at an appointment. Happy to be the one who is…
-
Biased agonism: a real phenomenon, an over-used explanation Started this topic · Pharmacology › Receptor biology · 22 Feb 2025 · 61 likes Posting this under the heading it deserves: Biased agonism: a real phenomenon, an over-used explanation Everything below is what sits behind that. Trying to work out…
-
A promotion I argued against, and why I lost Replied, post #107 · Documentation › Doc review · 22 Feb 2025 · 0 likes I read post #106 twice before replying, because I had assumed the opposite. On promotion I would separate what is worth knowing from what is worth acting on. The first…
-
Coming back to: Official shortage notices and what they authorise Replied, post #32 · Access › Shortages · 21 Feb 2025 · 0 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise. I am not the right person to answer…
-
Canadian access and provincial variation Replied, post #15 · Regional › North America · 24 Jan 2025 · 20 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #99 · Evidence › Journal club · 20 Jan 2025 · 0 likes What would change my mind on SURPASS-2 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #117 · Access › Insurance & coverage · 12 Jan 2025 · 0 likes Coming back to post #114, because the follow-up matters more than the original answer. Step therapy requirements looks different depending on whether you are reading…
-
What changed in 2026, by region Replied, post #24 · Access › International · 16 Dec 2024 · 25 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. Small point, but it…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #33 · Practice › Side effects · 10 Dec 2024 · 2 likes Worth separating two things that post #32 runs together. What I would want before treating nausea timeline as settled: the method, the sample, and whether anyone tried…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #13 · Practice › Interactions · 8 Dec 2024 · 7 likes Reading rather than answering, but this is the post I would point somebody at.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #36 · Practice › Side effects · 30 Nov 2024 · 0 likes My position on injection-site reactions is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #19 · Sourcing › Regulatory · 2 Nov 2024 · 0 likes Picking up post #16: that is the part I would want checked first. Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #64 · Clinical › Comorbidities · 19 Oct 2024 · 14 likes Post #60 describes the usual case. This is about the unusual one. A history of pancreatitis appears in the cautions for this class and the decision around it is one…
-
Progressive overload when the scale is falling — one year on Replied, post #133 · Nutrition & Training › Resistance training · 7 Oct 2024 · 5 likes The confident answers on Progressive overload and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Food noise reducing and the disorientation that can follow Replied, post #15 · Wellbeing › Mental health · 1 Oct 2024 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Signs of dehydration worth acting on Replied, post #19 · Safety › Adverse events · 21 Sep 2024 · 4 likes Where the signs of dehydration worth acting reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #55 · Clinical › Prescriber conversations · 11 Sep 2024 · 4 likes Worth separating two things that post #53 runs together. Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.…
-
Correlation in a self-tracked dataset: what it can support Replied, post #138 · Research Methods › Statistics · 25 Aug 2024 · 0 likes Worth separating correlation as a question about the compound from correlation as a question about the documentation. They get answered by different people and only one…
-
Journal club: FLOW and the renal composite, component by component Replied, post #27 · Evidence › Journal club · 11 Jul 2024 · 14 likes Adding the measurement that post #24 says would settle it. The baseline characteristics table is the single most useful page for the questions that get asked here,…